Skip to main content

Table 1 Resistance to cefixime, ciprofloxacin and azithromycin in Neisseria gonorrhoeae isolates from 21 EU/EEA countries, 2013

From: Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance

Country Antimicrobial Method of testing
Cefixime Ciprofloxacin Azithromycin
No. resistant No. tested % No. resistant No. tested % No. resistant No. tested %
Austria 7 109 6.4 78 109 71.6 6 109 5.5 Centralised
Belgium 7 110 6.4 62 110 56.4 2 110 1.8 Decentralised – MIC
Cyprus 0 9 0 8 9 88.9 3 9 33.3 Centralised
Denmark 13 110 11.8 64 110 58.2 10 110 9.1 Decentralised – Etest
France 4 112 3.6 50 112 44.6 0 112 0 Decentralised – Etest
Germany 13 101 12.9 64 101 63.4 4 101 4 Centralised
Greece 11 75 14.7 54 75 72 15 66 22.7 Decentralised – Etest
Hungary 6 88 6.8 60 88 68.2 2 88 2.3 Centralised
Iceland 0 5 0 2 5 40 0 5 0 Decentralised – Etest
Ireland 0 103 0 27 103 26.2 3 103 2.9 Decentralised – Etest
Italy 0 100 0 63 100 63 1 100 1 Decentralised – Etest
Latvia 1 38 2.6 10 38 26.3 6 38 15.8 Centralised
Malta 0 31 0 11 31 35.5 0 31 0 Decentralised – Etest
The Netherlands 0 139 0 48 139 34.5 2 139 1.4 Decentralised – Etest
Norway 5 112 4.5 89 112 79.5 12 112 10.7 Centralised
Portugal 0 110 0 52 110 47.3 20 110 18.2 Decentralised – Etest
Slovenia 1 73 1.4 46 73 63 0 73 0 Centralised
Slovakia 5 110 4.5 52 110 47.3 2 110 1.8 Centralised
Spain 18 119 15.1 78 119 65.5 10 119 8.4 Decentralised – MIC
Sweden 0 100 0 60 100 60 9 100 9 Decentralised – Etest
United Kingdom 2 240 0.8 77 240 32.1 1 240 0.4 Decentralised – MIC
Total 93 1994 4.7 1055 1994 52.9 108 1985 5.4  
95% CI    3.8 – 5.7    50.7 – 55.1    4.5 – 6.5  
  1. EU/EEA, European Union/European Economic Area; MIC, minimum inhibitory concentration using Etest and/or agar dilution method; CI, confidence interval of the mean %